Penggunaan Obat Herbal pada Pasien Kanker Serviks

  • MAKSUM RADJI UNIVERSITAS INDONESIA
  • HENDRI ALDRAT UNIVERSITAS INDONESIA
  • YAHDIANA HARAHAP UNIVERSITAS INDONESIA
  • COSPHIADI IRAWAN RUMAH SAKIT KANKER DHARMAIS JAKARTA

Abstract

Herbal medicines have widely been used to treat many type of diseases despite the advance of standard or conventional therapy. In fact, many people in Indonesia use medicinal plant as their customary part of life. Therefore, it is necessary to further explore the use of herbal medicines through modern perception. ln this study we would like to know the frequency and species of herbal medicines used among cervical cancer patients in National Cancer Hospital Dharmais, Jakarta, Indonesia and also to assess the relationship between age, education, jobs, stage of cancer, and payment status of the patients. The results were 61,8% patients used herbal medicines. The herbal medicines used most were mahkota dewa (Phaleria macrocarpa Scheetf Boerl.) 35.3%, temu putih (Curcuma zedoaria Rosc.) 32.4%, and buah merah (Pandanus conoideus Lam) 17,6%. There was a significant relationship (p=0,039) between the use of herbal medicines and stage of cancer but no relationship between age, education, occupation, income and payment status with the use of herbal medicines.

References

1. National Institute ef Health. Fact sheet cervical cancer.
Bethesda: National Institutes of Health; 2007.

2. Tjindarbumi D, Mangunkusumo R Cancer in Indonesia. present and future. Japan J. Clin Oncol. 2002. 32(l):S17-21.

3. Howley PM. Role ofthe human papillomaviruses in human cancer. Cancer Res. 1991.51:5019s -22s.

4. Koutsky LA, Holmes KK, Critchlowl CW. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. X Engl J Med. 1992. 327:1272-8.

5. American Cancer Society. Cervical Cancer. Diambil dari www.cancer.org. diakses tanggal 20- Juni 2005.

6. Ponten J, Adami HO, Bergstrom R. Strategies for global control of cervical cancer. Int J Cancer. 1995. 60:1-26.

7. Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Cases Control. 2001. 12:267-77.

8. Thingpen JT, Blessing JA, DiSaia PJ, Fowler WCJ. Hatch KD. Arandomized comparison ofa rapid versus prolonged (24 hr) iniiision of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group study. Gynecol Oncol 1989.32:198-202.

9. Omura GA. Chemotherapy for cervix cancer. Seminars in Oncol. 1994.21(1):54-56.

10. Heinrich M, Barnes J, Gibbons S, Williamson EM. Fundamentals of pharmacognosy and phytotheraphy Herbal remedies. N Engl J Med. 2002.347(25): 2046-56.

11. De Smet PAGM. Herval remedies. N Engl J Med.
2002.347(25):2046-56.

12. Paimin FR. Tanaman penawar sakit yang dicari pasar.
Trubus. 2001.382:15.

13. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by Women With early-stage breast cancer. NEngl J Med. 1999.340(22): 1733-9.

14. McKay DJ, Bentley JR, Grimshaw RN. Complementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Can. 2005.27(6):562-8.

15. Dalimarta S. Ramuan tradisional untuk pengobatan kanker. Jakarta: Penebar Svvadaya; 2007. hal. 1- 140.
16. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology. 2000.l8(l3):2505-14.

17. Lee AH, Ingraham SE, Kopp M, Foraida Ml, Jazieh, Rahman A. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J of Clin Oncology. 2006. 29:178-82.

18. Bailie GR, Johnson CA, Mason NA, Peter WLS. Medfacts pocket guide of drug interactions. 2nd edition. USA: Nephrology Pharmacy Associates, Inc.; 2003.

19. Jensen B. Herbal drug interaction chart. 2003. Diambil dari www. RxFiles.ca. Diakses tanggal 10 Februari 2009.

20. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients Who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002. 137:889-903.

21. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delba TL. Unconventional medicine in the United States. N Eng J Med. 1993.328(4):246-52.

22. Stoll K. Paying a premium: The added cost of care for the uninsured. Families USA Publication. 2005. No. 05-101.

23. Hesketh T, Wei XZ. Healthrin China: Traditional Chinese medicine: one country, two systems, BMJ. 1997.315:115-7.

24. Monesa N.. A critical literature review of the psychosocial effects of cervical cancer [mini- dissertation in Psycology]. J ohannesburg: Faculty of Arts, Rand Afrikaans University; 2003.

25. National Institutes of Health. The use of complementary and alternative medicine in the United States. National Center for Complementaryand Anternative Medicine. National Institutes of Health. 2005. Diambil dari www.nccam.nih.gov. Diakses tanggal 15 Juni 2005.
Published
2010-04-30
How to Cite
RADJI, MAKSUM et al. Penggunaan Obat Herbal pada Pasien Kanker Serviks. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 8, n. 1, p. 33-39, apr. 2010. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/364>. Date accessed: 24 nov. 2024.
Citation Formats
Issue
Vol 8 No 1 (2010): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.